Tempest Therapeutics Inc [TPST] stock is trading at $1.34, up 0.75%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The TPST shares have gain 4.69% over the last week, with a monthly amount glided 13.56%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Tempest Therapeutics Inc [NASDAQ: TPST] stock has seen the most recent analyst activity on March 14, 2024, when Scotiabank initiated its Sector Outperform rating and assigned the stock a price target of $13. Previously, Jefferies started tracking the stock with Buy rating on February 08, 2024, and set its price target to $15.
Tempest Therapeutics Inc [TPST] stock has fluctuated between $0.17 and $9.77 over the past year. Tempest Therapeutics Inc [NASDAQ: TPST] shares were valued at $1.34 at the most recent close of the market.
Analyzing the TPST fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.75, Equity is -2.01 and Total Capital is -1.15. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.68.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.2833 points at the first support level, and at 1.2267 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.3733, and for the 2nd resistance point, it is at 1.4067.
Ratios To Look Out For
For context, Tempest Therapeutics Inc’s Current Ratio is 2.17. As well, the Quick Ratio is 2.17, while the Cash Ratio is 2.14.
Transactions by insiders
Recent insider trading involved Versant Venture Capital VI, L., Owner, that happened on Aug 12 ’24 when 0.39 million shares were purchased. 10% Owner, Versant Venture Capital VI, L. completed a deal on Aug 08 ’24 to sell 0.4 million shares. Meanwhile, 10% Owner Versant Venture Capital VI, L. sold 0.39 million shares on Aug 12 ’24.
